Projects | HCA and TXA (n = 29) | TXA only (n = 30) | MD (95%CI) | P value | Cohen’D | |
---|---|---|---|---|---|---|
Duration of surgery (min) a | 77.2 ± 12.5 | 76.6 ± 11.2 | 0.6(-5.6-16.7) | 0.907 | 0.04 | |
IBL (mL) a | 148.3 ± 60.5 | 133.3 ± 56.2 | 15.0(-15.4-45.3) | 0.328 | 0.26 | |
TBL (mL) a | 1025.3 ± 305.3 | 892.4 ± 306.4 | 132.9(-26.6-294.4) | 0.079 | 0.44 | |
HBL (mL) a | 877.0 ± 294.6 | 759.0 ± 282.4 | 118.0(-32.4-268.4) | 0.122 | 0.41 | |
Hemoglobin (g/L) a | Â | Â | Â | Â | Â | |
 Postoperative 4 h | 117.7 ± 10.7 | 123.4 ± 13.8 | -5.7(-12.2-0.7) | 0.081 | -0.47 | |
 Postoperative day 1 | 106.7 ± 11.0 | 111.3 ± 12.6 | -4.6(-10.8-1.5) | 0.134 | -0.4 | |
 Postoperative day 2 | 100.9 ± 11.0 | 107.6 ± 12.5 | -7.6[-12.9-(-0.6)] | 0.032 | -0.57 | |
 Postoperative day 14 | 125.0 ± 10.8 | 126.3 ± 12.8 | -1.3(-8.0-5.4) | 0.7 | -0.11 | |
Albumin (g/L) a | Â | Â | Â | Â | Â | |
 Postoperative day 1 | 39.0 ± 1.9 | 39.1 ± 1.8 | -0.1(-1.1-0.8) | 0.772 | -0.08 | |
 Postoperative day 2 | 37.3 ± 2.0 | 37.7 ± 1.8 | -0.4(-1.3-0.6) | 0.46 | -0.19 | |
 Postoperative day 14 | 45.6 ± 1.9 | 45.7 ± 1.7 | -0.1[-0.4-(-0.1)] | 0.805 | -0.07 | |
 Transfusion (U) a | 0 | 0 | NA | NA | NA | |
Postoperative CRP (mg/L) a | Â | Â | Â | Â | Â | |
 Postoperative day 1 | 48.8 ± 33.5 | 45.1 ± 33.8 | 3.7(-13.8-21.3) | 0.655 | 0.11 | |
 Postoperative day 2 | 104.9 ± 52.0 | 94.2 ± 60.4 | 10.7(-18.7-40.2) | 0.282 | 0.19 | |
 Postoperative day 14 | 3.8 ± 1.9 | 3.4 ± 2.6 | 0.4(-0.7-1.7) | 0.083 | 0.21 | |
Postoperative IL-6 (pg/ml) a | Â | Â | Â | Â | Â | |
 Postoperative day 1 | 99.8 ± 105.4 | 99.6 ± 87.3 | 0.2(-50.2-50.6) | 0.555 | 0.01 | |
 Postoperative day 2 | 65.6 ± 36.3 | 57.9 ± 34.0 | 7.7(-10.6-26.1) | 0.405 | 0.22 | |
 Postoperative day 14 | 3.9 ± 3.0 | 3.2 ± 1.9 | 0.7(-0.6-2.0) | 0.307 | 0.29 | |
Pain VAS score a | Â | Â | Â | Â | Â | |
 Postoperative day 1 | 4.7 ± 1.4 | 4.5 ± 1.3 | 0.2(-0.5-0.8) | 0.741 | 0.12 | |
 Postoperative day 2 | 4.0 ± 0.9 | 4.0 ± 1.0 | -0.0(-0.5-0.5) | 0.881 | -0.04 | |
 Postoperative day 14 | 1.2 ± 1.2 | 1.2 ± 1.1 | 0.0(-0.2-0.7) | 0.996 | 0.45 | |
Complications b | Â | Â | Â | Â | Â | |
 DVT | 0 | 0 | NA | NA | / | |
 CMVT | 1 | 3 | 0.5(0.1–1.5) c | 0.612 | / | |
 PE | 0 | 0 | NA | NA | / | |
 incision infection | 0 | 0 | NA | NA | / | |
 Incision bleeding | 2 | 1 | 1.3(0.4–2.3) c | 0.612 | / | |
 Peri-incision bruise | 1 | 1 | 1.0(0.2–2.1) c | > 0.999 | / | |
 Allergic reaction | 0 | 0 | NA | NA | / | |
 Abnormal function of liver | 0 | 0 | NA | NA | / | |
 Abnormal function of kidney | 0 | 0 | NA | NA | / |